EUVIMEDEUVIMED entdecken
Crossref

NIR‐II Light Accelerated Prodrug Reduction of Pt(IV)‐Incorporating Pseudo Semiconducting Polymers for Robust Degradation and Maximized Photothermal/Chemo‐Immunotherapy

Dongsheng Tang, Huiling Zhou, Minhui Cui, Ganghao Liang, Hanchen Zhang, Haihua Xiao iD

Advanced Materials · 2023

DOI: 10.1002/adma.202300048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Dongsheng Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry Chinese Academy of Sciences, …. Hauptthemen laut MEDLINE: Prodrugs, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Selective activation of Pt(IV) prodrugs within tumors is particularly attractive because of their low damage to normal tissues. However, current common activation via chemical/photoreduction of Pt(IV) prodrugs into Pt(II) counterparts is limited by undesirable spatial–temporal control over this reduction process and the ineffective tissue penetration depth of undesirable light. Here, a pseudo‐conjugated‐polymer is designed via Stille polymerization, resulting in PSP‐Pt with a Pt(IV) prodrug of oxaliplatin (Oxa(IV)) in the polymer main chain that can be activated by NIR‐II light. PSP‐Pt can co‐assemble with a commercially available lipid polymer, namely mPEG 2k ‐DSPE, into NP PSP‐Pt . Under 1064 nm light irradiation, NP PSP‐Pt can be photoactivated to accelerate the Pt(IV) reduction to release oxaliplatin, thereby killing the cancer cells by photothermal effect and chemo‐immunotherapy inside a mouse model with CT26 colon cancer. This work reports the application of NIR‐II light for accelerating Pt(IV) reduction for cancer tumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsNanoparticlesNeoplasmsMiceAnimalsPolymersOxaliplatinImmunotherapyCell Line, Tumor

Stichwörter der Autor:innen

NIR-II photothermal therapychemo-immunotherapyoxaliplatinpseudo-conjugated-polymers

Substanzen

ProdrugsPolymersOxaliplatin

Autor:innen und Institutionen

  • Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry Chinese Academy of Sciences, Beijing, 100190, P. R. China.
  • University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.

ORCID-Profile: Haihua Xiao

Förderung

  • Natural Science Foundation of Beijing of China
  • National Natural Science Foundation of China

Zitieren

APA

Tang, D., Zhou, H., Cui, M., Liang, G., Zhang, H., & Xiao, H. (2023). NIR‐II Light Accelerated Prodrug Reduction of Pt(IV)‐Incorporating Pseudo Semiconducting Polymers for Robust Degradation and Maximized Photothermal/Chemo‐Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.202300048

Vancouver

Tang D, Zhou H, Cui M, Liang G, Zhang H, Xiao H. NIR‐II Light Accelerated Prodrug Reduction of Pt(IV)‐Incorporating Pseudo Semiconducting Polymers for Robust Degradation and Maximized Photothermal/Chemo‐Immunotherapy. Advanced Materials. 2023. doi:10.1002/adma.202300048

BibTeX
@article{Tang2023,
  author = {Tang, Dongsheng and Zhou, Huiling and Cui, Minhui and Liang, Ganghao and Zhang, Hanchen and Xiao, Haihua},
  title = {NIR‐II Light Accelerated Prodrug Reduction of Pt(IV)‐Incorporating Pseudo Semiconducting Polymers for Robust Degradation and Maximized Photothermal/Chemo‐Immunotherapy},
  journal = {Advanced Materials},
  year = {2023},
  doi = {10.1002/adma.202300048}
}
Kostenlos starten →